Search research articles
Contact Us
Filters
Showing results (251-260 of 284) with videos related to
Page
of 29
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
January 3, 2023
Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials
Paul L Nguyen, Huei-Chung Rebecca Huang, Daniel E Spratt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 31, 2004
Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working Group
Howard I Scher, Mario Eisenberger, Anthony V D'Amico, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 4, 2021
Adding Short-Term Androgen Deprivation Therapy to Radiation Therapy in Men With Localized Prostate Cancer: Long-Term Update of the NRG/RTOG 9408 Randomized Clinical Trial
Christopher U Jones, Stephanie L Pugh, Howard M Sandler, et al.
Cancer
|
December 29, 2022
Body composition and mortality in men receiving prostate radiotherapy: A pooled analysis of NRG/RTOG 9406 and NRG/RTOG 0126
Andrew M McDonald, Lyudmila DeMora, Eddy S Yang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 19, 2018
Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer
Himanshu R Lukka, Stephanie L Pugh, Deborah W Bruner, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 30, 2021
Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findings
Ursula M Vogl, Tomasz M Beer, Ian D Davis, et al.
The Lancet. Oncology
|
October 15, 2018
Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial
Mack Roach, Jennifer Moughan, Colleen A F Lawton, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 10, 2010
NCCN clinical practice guidelines in oncology: prostate cancer
James Mohler, Robert R Bahnson, Barry Boston, et al.
European Urology Focus
|
February 2, 2024
Cardiovascular Mortality and Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-term Update of NRG/RTOG 9202
Kimberley S Mak, Molly Scannell Bryan, James J Dignam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 13, 2020
Addition of Androgen-Deprivation Therapy or Brachytherapy Boost to External Beam Radiotherapy for Localized Prostate Cancer: A Network Meta-Analysis of Randomized Trials
William C Jackson, Holly E Hartman, Robert T Dess, et al.
Page
of 29
Search research articles
Search
Showing results (251-260 of 284) with videos related to
Sort By:
Page
of 29
International Journal of Radiation Oncology, Biology, Physics
|
January 3, 2023
Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials
Paul L Nguyen, Huei-Chung Rebecca Huang, Daniel E Spratt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 31, 2004
Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working Group
Howard I Scher, Mario Eisenberger, Anthony V D'Amico, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 4, 2021
Adding Short-Term Androgen Deprivation Therapy to Radiation Therapy in Men With Localized Prostate Cancer: Long-Term Update of the NRG/RTOG 9408 Randomized Clinical Trial
Christopher U Jones, Stephanie L Pugh, Howard M Sandler, et al.
Cancer
|
December 29, 2022
Body composition and mortality in men receiving prostate radiotherapy: A pooled analysis of NRG/RTOG 9406 and NRG/RTOG 0126
Andrew M McDonald, Lyudmila DeMora, Eddy S Yang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 19, 2018
Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer
Himanshu R Lukka, Stephanie L Pugh, Deborah W Bruner, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 30, 2021
Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findings
Ursula M Vogl, Tomasz M Beer, Ian D Davis, et al.
The Lancet. Oncology
|
October 15, 2018
Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial
Mack Roach, Jennifer Moughan, Colleen A F Lawton, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 10, 2010
NCCN clinical practice guidelines in oncology: prostate cancer
James Mohler, Robert R Bahnson, Barry Boston, et al.
European Urology Focus
|
February 2, 2024
Cardiovascular Mortality and Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-term Update of NRG/RTOG 9202
Kimberley S Mak, Molly Scannell Bryan, James J Dignam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 13, 2020
Addition of Androgen-Deprivation Therapy or Brachytherapy Boost to External Beam Radiotherapy for Localized Prostate Cancer: A Network Meta-Analysis of Randomized Trials
William C Jackson, Holly E Hartman, Robert T Dess, et al.
Page
of 29